Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Home - The Pharma Times | Pharma & Health Care News Portal
Wednesday, April 24, 2024

Biomedical Software Startup BostonGene Secures $50M in Series A Financing from...

New Delhi, April 26, 2019: NEC Corporation (TSE: 6701) and BostonGene Corporation (BostonGene), a Boston, Mass-based biomedical software company, has announced a $50M series...

Biotechnology

Apex Group of Hospitals Doctors use Botox treatment to restore Mumbai Falooda Seller voice...

Mumbai, August 22, 2023:  Mumbai- 40-year-old vendor from Bhayander by profession falooda seller Nishikanat Bhagwat (name changed)  was suffering from a voice problem from...

ESDS launches AA+ Covid 19 testing solution that indicates disease in less than 5...

Nashik,  May 20, 2020: One of India’s leading IT Solution company, ESDS Software Solution Pvt. Ltd. has come up with a rapid COVID-19 detection solution,...

IT & Software Support

Appointments

Lupin appoints Ms. Christine Mundkur as an Independent Director

Mumbai, April 02, 2019: Pharma major Lupin Limited (Lupin) announced today the appointment of Ms. Christine Mundkur as an Independent Director with...
Leena Srivastava appointed IIASA Deputy Director General for Science

Leena Srivastava appointed IIASA Deputy Director General for Science

New Delhi, August 29, 2019:The Vice Chancellor of the TERI School of Advanced Studies, New Delhi, Leena Srivastava will join the International Institute for...

Awards

ABLE Invites Online Entries from Innovators to Award the Best Biotech Innovations of the...

Bangalore, Karnataka, India, Friday, December 21, 2012 -- (Business Wire India) -- The Executive Council of the Association of Biotechnology Led Enterprises (ABLE), the apex body of the biotech sector in India announced that entries for its prestigious biotech (BT) innovation awards will be accepted till January 15th, 2013 from Indian as well as global biotech innovators. The finalists for the best BT Innovations will be shortlisted in February and the winners will be awarded at ABLE's Tenth Anniversary planned for March 11 in New Delhi.

India was rated 47th in its biotech Innovation abilities in an International survey earlier this year following which ABLE India planned and created a platform to recognize and award the best work by biotech professionals from India as well globally to instill the significance of biotech innovations by institutionalizing 'Best Biotech Innovations of the 21st Century (2001 - 2012)'. Entries in 15 categories for biotech innovations are being invited and the best innovations will be shortlisted based on various parameters. A Jury Panel comprising of national and International experts will select the Awardees.

Financial Results

Approvals

Clinical Trails

Bulk Drug

Health Care

Alternative Medicine

Eye Care

Sankara Eye Hospital provides AI Driven Smart Vision Glasses Free of Cost to 25...

Bengaluru, October 14, 2023: In a remarkable and heart-warming event, Sankara Eye Hospital, a leading institution in eye care enabled AI driven smart glasses to...

Importance of eye health during this lockdown and 5 ways to keep our eyes...

By Hemanth Manay, CEO & Chief Consultant Optometrist, S.R. Gopal Rao Opticians & Optometrists The current situation does not allow for us to move out...

Product News

Media Partners

Spotlight

Investments

Packaging

Latest News

Dental Care

Hospital Management

Drug Discovery & Development

Suppliers

Technology

TRAMS Protocol – Pooled Testing For COVID-19 (RT-PCR) Test

Thyrocare publishes TRAMS (Thyrocare Reliable Affordable Mass Screening) Protocol for pooled testing of COVD-19 (RT-PCR) in India to fight the shortage to testing kits Mumbai,...

Companies

Glenmark buoyed by speciality, generics businesses

Drug-maker Glenmark said that its specialty drugs and generics businesses performed well in the year ended March 2013.

“The US, India and Russia businesses continued to maintain its high growth trajectory,” said Glenn Saldanha, Chairman and Managing Director.

The company also made some progress on its research front with five new chemical entities and new biological entities getting into clinical trials, including Crofelemer which recently received approval from the US Food and Drug Administration for HIV associated diarrhoea, he added.

In the three months ended March 31, 2013, the company's revenues from the generics business was Rs 586 crore against Rs 468 crore in the corresponding period the previous year, a growth of 25 per cent. The specialty medicines business excluding out-licensing revenue was at Rs 741 crore against Rs 594 crore for the corresponding previous quarter, recording a growth of 24 per cent, the company said.

Marketing

Our Partners

Machinery & Equipments